NVENTA BIOPHARMACEUTICALS CORP has a total of 32 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are CISTEM BIOTECHNOLOGIES GMBH, ADISTEM LTD and OZAWA KEIYA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Republic of Korea | 3 | |
#5 | United States | 3 | |
#6 | Brazil | 2 | |
#7 | Canada | 2 | |
#8 | China | 2 | |
#9 | Mexico | 2 | |
#10 | Hong Kong | 1 | |
#11 | Hungary | 1 | |
#12 | Israel | 1 | |
#13 | Japan | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Emtage Peter | 19 |
#2 | Siegel Marvin | 15 |
#3 | Webb John | 8 |
#4 | Rowse Gerry | 8 |
#5 | Mizzen Lee | 4 |
#6 | Winnett Mark | 3 |
#7 | Goldstone Stephen | 3 |
#8 | Neefe John | 3 |
#9 | Winnett Mark T | 2 |
#10 | Neefe John R | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010054482A1 | Immunogenic human papillomavirus compositions | |
WO2009086640A1 | Adjuvant compositions comprising poly-ic and a cationic polymer | |
CA2680060A1 | Double-stranded locked nucleic acid compositions | |
WO2007137427A1 | Bioactive purified hspe7 compositions | |
AU2005201826A1 | Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins | |
AU2001271449B2 | Human papilloma virus treatment |